Craniometaphyseal dysplasia
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Craniometaphyseal dysplasia is a rare condition characterised by thickening (overgrowth) of bones in the skull (cranium) and abnormalities in a region at the end of long bones known as the metaphysis. The abnormal bone growth continues throughout life. Except in the most severe cases, the lifespan of people with craniometaphyseal dysplasia is normal.
Video picks for Genetic conditionsVideo library
Description
Craniometaphyseal dysplasia is a rare condition characterised by thickening (overgrowth) of bones in the skull (cranium) and abnormalities in a region at the end of long bones known as the metaphysis. The abnormal bone growth continues throughout life. Except in the most severe cases, the lifespan of people with craniometaphyseal dysplasia is normal.
Bone overgrowth in the head causes many of the signs and symptoms of craniometaphyseal dysplasia. Affected individuals typically have distinctive facial features such as a wide nasal bridge, a prominent forehead, wide-set eyes (hypertelorism), and a prominent jaw. Excess bone formation in the jaw can delay teething (dentition) or result in absent (non-erupting) teeth. Infants with craniometaphyseal dysplasia may have breathing or feeding problems caused by narrow nasal passages. In severe cases, abnormal bone growth can pinch (compress) the nerves that extend from the brain to various areas of the head and neck (cranial nerves). Compression of the cranial nerves can lead to paralyzed facial muscles (facial nerve palsy), blindness, or deafness.
The x-rays of individuals with craniometaphyseal dysplasia show unusually shaped long bones, particularly long bones in the legs. The ends of these bones are wider and appear less dense than usual in people with this condition.
There are two types of craniometaphyseal dysplasia, which are distinguished by their pattern of inheritance and genetic cause. They are known as the autosomal dominant and autosomal recessive types.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive; Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Autosomal dominant craniometaphyseal dysplasia
Autosomal recessive craniometaphyseal dysplasia
CMD
CMDD
CMDJ
CMDR
Craniometaphyseal dysplasia, Jackson type
Patient picks for Genetic conditions

Bones, joints and muscles
Things you might not know about cleidocranial dysplasia
The release of Stranger Things 5 has set us up for a season bursting with nostalgia, excitement, and the heartwarming thrill of friends banding together to face evil. Not only does the show’s finale promise an epic, adventure-packed send-off to 2025, but it also sparks a resurgence of interest in a relatively little-known health condition. Cleidocranial dysplasia (CCD) is a rare inherited condition that affects how teeth and bones develop. Its signs can show up differently in each person, making every case unique. In this article, we take a closer look at CCD and the symptoms that may come with it.
by Victoria Raw

Children's health
Developmental dysplasia of the hip
Developmental dysplasia of the hip is a problem with the way that the hip joint develops. It is usually present from birth although may develop later. It is more common in girls. When developmental dysplasia of the hip is diagnosed and treated early in a young baby, the outcome is usually excellent. If treatment is delayed, the treatment is more complex and has less chance of being successful.
by Dr Jacqueline Payne, FRCGP
Related patient information and medicines

Patient information leaflet
Restricted growth
Dwarfism is a medical or genetic condition which causes people to have restricted growth so that they are shorter than average. Specifically, people with dwarfism grow no higher than 4 ft 10 ins (147 cm). It tends to be associated with other problems such as a cleft palate, club feet, chest abnormalities and abnormally shaped ears..

Patient information leaflet
Hip problems
Your doctor will check this out. [https://patient.info/health/hip-problems](https://patient.info/health/hip-problems) Causes of hip problems in children Developmental dysplasia of the hip (DDH) A painless condition that can affect newborns, DDH makes the hip joint unstable so that it can dislocate (something that very rarely happens to the hip.

Patient information leaflet
Dislocation
A dislocation is an injury in which the bones in a joint are forced apart and out of their usual positions. To dislocate the bones of a large joint usually needs considerable force (although there are exceptions to this). Developmental dysplasia of the hip. For more information see the separate leaflet called Developmental Dysplasia of the Hip..

Patient information leaflet
Joint pain
What is joint pain (arthralgia). Joint pain is discomfort that arises from any joint. The medical word for joint pain is arthralgia. This is different to the word arthritis , which means inflammation of the joint, which causes pain and sometimes warmth, redness and/or swelling of the joint. A joint can be painful without being inflamed, or it can.

Patient information leaflet
Barrett's oesophagus
ServiceUpsellPlaceholder Is Barrett's oesophagus harmful. The changed cells of Barrett's oesophagus are not cancerous (malignant). However, these cells have an increased risk, compared with normal gullet (oesophageal) cells, of turning cancerous in time. The changed cells in Barrett's oesophagus can develop something called dysplasia. A cell with.

Patient information leaflet
Newborn screening test
The test... You can read more about these conditions in the sections linked to the various tests as above. For example, if your baby is found to have a condition where their hip joint is not stable ( developmental dysplasia of the hip Pregnancy ), the joint can be stabilised by putting them in a harness or a plaster cast for a while. Although this.
Further reading and references
- Craniometaphyseal dysplasia; MedlinePlus, National Library of Medicine.
- Addison WN, Azari F, Sorensen ES, Kaartinen MT, McKee MD. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem. 2007 May 25;282(21):15872-83. doi: 10.1074/jbc.M701116200. Epub 2007 Mar 23.
- Hu Y, Chen IP, de Almeida S, Tiziani V, Do Amaral CM, Gowrishankar K, Passos-Bueno MR, Reichenberger EJ. A novel autosomal recessive GJA1 missense mutation linked to Craniometaphyseal dysplasia. PLoS One. 2013 Aug 12;8(8):e73576. doi: 10.1371/journal.pone.0073576. eCollection 2013.
- Iughetti P, Alonso LG, Wilcox W, Alonso N, Passos-Bueno MR. Mapping of the autosomal recessive (AR) craniometaphyseal dysplasia locus to chromosome region 6q21-22 and confirmation of genetic heterogeneity for mild AR spondylocostal dysplasia. Am J Med Genet. 2000 Dec 18;95(5):482-91. doi: 10.1002/1096-8628(20001218)95:53.0.co;2-x.
- Nurnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H, Leschik G, Uhlmann K, Mischung C, Harrop K, Goldblatt J, Borochowitz ZU, Kotzot D, Westermann F, Mundlos S, Braun HS, Laing N, Tinschert S. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet. 2001 May;28(1):37-41. doi: 10.1038/ng0501-37.
- Reichenberger E, Chen IP. Autosomal Dominant Craniometaphyseal Dysplasia. 2007 Aug 27 [updated 2025 Aug 14]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1461/
- Reichenberger E, Tiziani V, Watanabe S, Park L, Ueki Y, Santanna C, Baur ST, Shiang R, Grange DK, Beighton P, Gardner J, Hamersma H, Sellars S, Ramesar R, Lidral AC, Sommer A, Raposo do Amaral CM, Gorlin RJ, Mulliken JB, Olsen BR. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet. 2001 Jun;68(6):1321-6. doi: 10.1086/320612. Epub 2001 Apr 16.
- Talbot J, Brion R, Lamora A, Mullard M, Morice S, Heymann D, Verrecchia F. Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblasts. J Cell Physiol. 2018 Feb;233(2):946-957. doi: 10.1002/jcp.25938. Epub 2017 May 23.
- Zaka R, Williams CJ. Role of the progressive ankylosis gene in cartilage mineralization. Curr Opin Rheumatol. 2006 Mar;18(2):181-6. doi: 10.1097/01.bor.0000209432.36355.6e.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

